Manulife (Manufacturers Life Insurance)
OLMA icon

Manulife (Manufacturers Life Insurance)’s Olema Pharmaceuticals OLMA Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
89,990
-19,592
-18% -$262K ﹤0.01% 1908
2026
Q1 		$1.63M Buy
109,582
+7,260
+7% +$162K ﹤0.01% 1575
2025
Q4 		$2.56M Buy
102,322
+81,781
+398% +$1.46M ﹤0.01% 1422
2025
Q3 		$201K Sell
20,541
-1,901
-8% -$11.4K ﹤0.01% 2578
2025
Q2 		$95.6K Buy
22,442
+7,146
+47% +$31.9K ﹤0.01% 2768
2025
Q1 		$57.5K Buy
15,296
+172
+1% +$865 ﹤0.01% 2811
2024
Q4 		$88.2K Sell
15,124
-337
-2% -$3.37K ﹤0.01% 2848
2024
Q3 		$185K Sell
15,461
-427
-3% -$5.46K ﹤0.01% 2700
2024
Q2 		$172K Buy
15,888
+5,449
+52% +$59.1K ﹤0.01% 2663
2024
Q1 		$118K Sell
10,439
-487
-4% -$6.28K ﹤0.01% 2740
2023
Q4 		$153K Sell
10,926
-896
-8% -$12K ﹤0.01% 2711
2023
Q3 		$146K Sell
11,822
-45
-0.4% -$459 ﹤0.01% 2697
2023
Q2 		$107K Buy
+11,867
New +$71.6K ﹤0.01% 2825
2022
Q2 		– Sell
-12,234
Closed -$52.1K – 3095
2022
Q1 		$52.1K Sell
12,234
-2,017
-14% -$11.1K ﹤0.01% 3038
2021
Q4 		$133K Buy
14,251
+1,018
+8% +$21.1K ﹤0.01% 3006
2021
Q3 		$365K Buy
13,233
+5,941
+81% +$160K ﹤0.01% 2519
2021
Q2 		$204K Buy
7,292
+449
+7% +$12.8K ﹤0.01% 3090
2021
Q1 		$227K Buy
+6,843
New +$293K ﹤0.01% 2814

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OLMA Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Olema Pharmaceuticals (OLMA) stake by 18% in Q2 2026, selling an estimated $262K and leaving 89,990 shares worth $1.13M. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Manulife (Manufacturers Life Insurance) first reported a position in OLMA in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.56M in Q4 2025. 184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 89,990 shares of Olema Pharmaceuticals worth $1.13M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 19,592 Olema Pharmaceuticals shares in Q2 2026, an estimated $262K.
  • Olema Pharmaceuticals made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1908 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 18 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Olema Pharmaceuticals position peaked at $2.56M in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.